Effect of sequential implanting with Synovex on steer and heifer performance.
Studies were conducted using 72 (Exp. 1) and 248 (Exp. 2) steer and heifer calves from 1 to 2 mo of age through slaughter to determine whether preweaning implants affect postweaning feed conversion of cattle that are rapidly grown and(or) finished in the feedlot. In Exp. 1, treatments were three Synovex (S) implants administered 0, 70, and 140 d postweaning (NSSS) or Synovex-C (C) administered preweaning and three implants administered postweaning (CSSS). In Exp. 2, treatments were no implants (NNNN), implants administered 0, 74, and 148 d postweaning to calves that had either received no preweaning implant (NSSS), or C (CSSS), and CSSS plus trenbolone acetate (TBA) administered with the last S implant (CSSS-TBA). Synovex-S or -H implants were administered postweaning to steers and heifers, respectively. Steer and heifer calves implanted with C in the preweaning phase were 9.0 and 13.0 kg (Exp. 1) and 7.5 and 15.0 kg (Exp. 2) heavier (P < .10), respectively, at weaning than nonimplanted steer and heifer calves. In Exp. 1, preweaning implant had no affect on postweaning performance or quality grade. In Exp. 2, preweaning implants (NSSS vs CSSS) decreased (P < .10) steer postweaning gains, whereas postweaning implants (NSSS vs NNNN) increased (P < .10) DM intake; however, feed:gain ratio was not affected by implant strategy. Heifers in Exp. 2 that received implants had greater postweaning (P < .10) DM intakes and daily gains than heifers not receiving implants (NNNN); however, feed:gain ratios among treatment groups were unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)
Mader
T L
TL
University of Nebraska, Northeast Research and Extension Center, Concord 68728.
Dahlquist
J M
JM
Sindt
M H
MH
Stock
R A
RA
Klopfenstein
T J
TJ
D045930:Anabolic Agents / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D002417:Cattle / Q000254:growth & development*; D004338:Drug Combinations; D004343:Drug Implants; D004435:Eating / Q000187:drug effects; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D008297:Male; D008460:Meat / Q000592:standards; D024510:Muscle Development; D009132:Muscles / Q000187:drug effects; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*; D011897:Random Allocation; D013739:Testosterone / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors; D014204:Trenbolone Acetate / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D014886:Weaning; D015430:Weight Gain / Q000187:drug effects
D045930:Anabolic Agents; D004338:Drug Combinations; D004343:Drug Implants; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D014204:Trenbolone Acetate